Universal Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UVV research report →
Price Chart
About the company
Universal Corporation is a global agricultural enterprise specializing in the processing and supply of leaf tobacco and a diverse range of plant-based ingredients. Its activities are organized into two primary segments: Tobacco Operations and Ingredients Operations. Within its Tobacco Operations, the company manages the entire supply chain, encompassing the procurement, financing, processing, packing, storage, and distribution of leaf tobacco to global manufacturers of consumer tobacco products.
- CEO
- Preston Douglas Wigner
- IPO
- 1988
- Employees
- 11,250
- HQ
- Richmond, VA, US
Get TickerSpark's AI analysis on UVV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $803.40M
- P/E
- -351.90
- Fwd P/E
- 10.43
- PEG
- 3.44
- P/S
- 0.32
- P/B
- 0.63
- EV/EBITDA
- 11.95
- Div Yield
- 9.38%
- Gross Margin
- 16.45%
- Op Margin
- 5.58%
- Net Margin
- -0.09%
- ROE
- -0.17%
- ROIC
- 1.73%
Latest fiscal year · YoY change
- Revenue
- $2.92B-0.8%
- Gross Profit
- $512.02M-6.7%
- Op Income
- $211.34M
- Net Income
- $32.64M-65.7%
- EPS
- $1.30-65.9%
- OCF Growth
- -60.5%
- FCF Growth
- -69.6%
- 52W High
- $59.38
- 52W Low
- $32.18
- 50D MA
- $40.80
- 200D MA
- $49.11
- Beta
- 0.60
- RSI (14)
- 20
- Avg Volume
- 384.00K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Universal reported a weak second quarter driven by delayed tobacco shipments and ongoing Ingredients pressure, but management said the business remains on track for a stronger second half with inventories moving down and customer commitments intact.· November 5, 2026
- Tobacco results were pushed into the second half as customers delayed shipping instructions in the oversupply cycle.
- Uncommitted tobacco inventory fell to 19% of inventory and estimated unsold flue-cured and burley stocks were about 134 million kilos, down approximately 45 million kilos from June 30.
- Ingredients remained under pressure from weak CPG demand, inflation, high raw material costs, and a tight apple supply market.
- Management expects tobacco shipments and results to be heavily weighted to Q3 and Q4, with potential upside from customer buying tied to El Niño concerns.
- The company reiterated a focus on deleveraging over time as working capital moderates and interest expense is reduced.
Second-quarter fiscal 2027 consolidated revenue was $622 million, down 18% year over year; operating income was $43 million versus $68 million last year; and net income attributable to Universal Corporation was $13 million versus $34 million last year. For the first half, revenue was $1.1 billion, down 15% year over year; operating income was $45 million versus $102 million; and net income attributable to Universal was $8 million versus $43 million. Tobacco segment Q2 revenue was $534 million, down 19%, with operating income of $44 million versus $65 million; first-half revenue was $972 million, down 17%, with operating income of $47 million, down 53%. Ingredients Q2 revenue was $88 million, down 8%, with an operating loss of $2 million; first-half revenue was $174 million, down 5%, with an operating loss of $2.7 million. As of September 30, 2026, net debt was $1.15 billion, about $82 million higher year over year, and liquidity availability was approximately $945 million. Management said full-year results should be heavily weighted to the second half, with tobacco gross profit margin expected to remain in the 17% to 19% range and SG&A still expected around $300 million to $310 million; interest expense was described as tracking in line with year-to-date trends.
Preston Wigner framed the quarter as a timing issue rather than a demand problem in tobacco, saying customer commitments remain in line with the full-year sales plan and that the company entered the second half encouraged by its position in the market. He emphasized Universal’s ability to navigate cycles, protect margins, and move large volumes in the back half of the year, while also noting emerging customer interest tied to El Niño risk. On Ingredients, he said the business is being reorganized around Fruit, Dry, and Taste solutions, with a long-term push toward better commercialization, facility utilization, and efficiency.
Steve Diel said the quarter was hurt by a slower start to the tobacco cycle and continued Ingredients headwinds. He highlighted the key financials: consolidated Q2 revenue of $622 million, operating income of $43 million, and net income of $13 million; first-half consolidated revenue of $1.1 billion, operating income of $45 million, and net income of $8 million. He also noted net debt of $1.15 billion, liquidity of about $945 million, and said working capital usage should moderate as the cycle normalizes, creating an opportunity to delever and reduce interest expense. In Q&A, he said gross profit as a percent of revenue has historically been in the 17% to 19% range and that current forecasts show something comparable.
Analysts focused on how to think about a normal first-half/second-half split, whether El Niño could pull forward tobacco demand, and whether margins should improve in the back half. Management said there is no single clean baseline because shipment timing, carryover, and weather all change year to year, but the normal pattern is still heavily second-half weighted. On El Niño, they said there are opportunities for extra sales, but it is too early to quantify because customer buying will depend on timing, grades, and how weather risks develop. They also confirmed the full-year tobacco gross margin outlook remains in the 17% to 19% range and said tobacco operating margin should improve in the second half, while the Ingredients business remains difficult and may not show clear quarter-to-quarter improvement soon.
The positive case is that tobacco demand appears intact: customer commitments are in line with the full-year plan, uncommitted inventory has fallen to 19%, and management expects a back-half-heavy recovery. There may also be incremental upside from customers buying ahead of El Niño-related crop risk, and management sounded confident it can move the volume while keeping margins in a historical 17% to 19% range. The company also has long-term support from its diversified footprint, century of experience, and a stated plan to delever as working capital eases.
The quarter showed meaningful earnings pressure from delayed tobacco shipments and persistent Ingredients weakness, with consolidated revenue and net income down sharply year over year. Management acknowledged logistics risks, including port congestion and container availability, and said the El Niño opportunity is too early to quantify. Ingredients remains challenged by weak CPG demand, inflation, high raw material costs, and an ongoing transformation that may not produce quick results.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.5%
- Shares Outstanding
- 24.93M
- Float Shares
- 24.30M
of shares held by institutions
240 13F filers
Buy/sell ratio 8.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for UVV, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 3.87M | ▼ 23.51K |
| Vanguard Group Inc | 2.98M | ▲ 35.51K |
| Dimensional Fund Advisors LP | 1.74M | ▼ 28.40K |
| Vanguard Portfolio Management LLC | 1.65M | ▼ 156.50K |
| State Street Corp | 1.50M | ▲ 54.68K |
| Invesco Ltd. | 1.07M | ▲ 315.31K |
| Vanguard Capital Management LLC | 1.06M | ▼ 55.28K |
| Geode Capital Management, LLC | 647.90K | ▼ 250 |
| Sixth Street Partners Management Company, L.P. | 424.68K | ▲ 424.68K |
| Charles Schwab Investment Management Inc | 424.68K | ▼ 53.34K |
| Prudential Financial Inc | 402.34K | ▼ 7.61K |
| Qube Research & Technologies Ltd | 383.57K | ▲ 93.91K |
Held by 272 ETFs
Biggest fund positions in UVV by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 4, 26 | FRIEDMAN GREGORY R | other | 0 |
| Oct 1, 26 | Wigner Preston Douglas | other | 6,469 |
| Aug 10, 26 | Freeman Lennart R. | sell | 1,782 |
| Aug 4, 26 | Williams Jacqueline T. | other | 2,650 |
| Aug 4, 26 | Cantor Diana F | other | 2,650 |
| Aug 4, 26 | Schick Arthur J. Jr. | other | 2,650 |
| Aug 4, 26 | Tullidge Thomas H Jr | other | 2,650 |
| Aug 4, 26 | SLEDD ROBERT C | other | 2,650 |
| Aug 4, 26 | Manolios Fotini Emanuel | other | 2,650 |
| Aug 4, 26 | Trojan Greg | other | 4,580 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UVV coverage
Recent articles, reports, and earnings notes.
Want a deeper read on UVV?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Universal Corporation: This Dividend King's 9% Yield Is Flashing Warning Signs
seekingalpha.com · Nov 19
Universal Insurance Holdings: A Renewed Repurchase Program, Special Dividend, And 40% ROE Make This Insurer A Buy
seekingalpha.com · Nov 19
Universal Music Group N.V. (UNVGY) Presents at Morgan Stanley European Technology, Media and Telecom Conference Transcript
seekingalpha.com · Nov 18
Universal Health Services, Inc. Announces Dividend
globenewswire.com · Nov 18
Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results
prnewswire.com · Nov 18
22nd Century Group (NASDAQ:XXII) and Universal (NYSE:UVV) Critical Analysis
defenseworld.net · Nov 17
Universal Health Services Bets on Hospital Recovery as Medicaid Payments Fall in 2027
marketbeat.com · Nov 15
Universal Display: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
